Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

A Vogel¹, A Cervantes², I Chau³, B Daniele⁴, J M Llovet^{5

6

7}, T Meyer^{8

9}, J-C Nault¹⁰, U Neumann¹¹, J Ricke¹², B Sangro¹³, P Schirmacher¹⁴, C Verslype¹⁵, C J Zech¹⁶, D Arnold¹⁷, E Martinelli¹⁸; ESMO Guidelines Committee

Affiliations

¹ Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.
² Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
³ Department of Medicine, Royal Marsden Hospital, Surrey, UK.
⁴ Direttore Dipartimento di Oncologia e U.O.C. Oncologia Medica A.O., Benevento, Italy.
⁵ Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, Mount Sinai Liver Cancer Program, New York, USA.
⁶ Barcelona-Clínic Liver Cancer Group (BCLC), Unitat d'Hepatologia, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona.
⁷ Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
⁸ Oncology, Royal Free Hospital, London.
⁹ UCL Cancer Institute, University College London, London, UK.
¹⁰ Service d'hépatologie, Hôpital Jean Verdier, Bondy, France.
¹¹ Klinik für Allgemein- und Viszeralchirurgie, Medizinische Fakultät der RWTH Aachen.
¹² Klinik und Poliklinik für Radiologie, Ludwig-Maximilians-Universität München, Munich, Germany.
¹³ Liver Unit, Clinica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.
¹⁴ Institute of Pathology, University Hospital, Heidelberg, Germany.
¹⁵ Campus Gasthuisberg, UZ Leuven, Leuven, Belgium.
¹⁶ Klinik für Radiologie und Nuklearmedizin Universität Basel, Basel, Switzerland.
¹⁷ Department Oncology, Section Hematology and Palliative Care AK Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany.
¹⁸ Faculty of Medicine, Università della Campania L. Vanvitelli Naples, Caserta, Italy.

PMID: 30285213
DOI: 10.1093/annonc/mdy308

Free article

Practice Guideline

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

A Vogel et al. Ann Oncol. 2018.

Free article

. 2018 Oct 1;29(Suppl 4):iv238-iv255.

doi: 10.1093/annonc/mdy308.

Authors

Affiliations

¹ Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.
² Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
³ Department of Medicine, Royal Marsden Hospital, Surrey, UK.
⁴ Direttore Dipartimento di Oncologia e U.O.C. Oncologia Medica A.O., Benevento, Italy.
⁵ Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, Mount Sinai Liver Cancer Program, New York, USA.
⁶ Barcelona-Clínic Liver Cancer Group (BCLC), Unitat d'Hepatologia, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona.
⁷ Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
⁸ Oncology, Royal Free Hospital, London.
⁹ UCL Cancer Institute, University College London, London, UK.
¹⁰ Service d'hépatologie, Hôpital Jean Verdier, Bondy, France.
¹¹ Klinik für Allgemein- und Viszeralchirurgie, Medizinische Fakultät der RWTH Aachen.
¹² Klinik und Poliklinik für Radiologie, Ludwig-Maximilians-Universität München, Munich, Germany.
¹³ Liver Unit, Clinica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.
¹⁴ Institute of Pathology, University Hospital, Heidelberg, Germany.
¹⁵ Campus Gasthuisberg, UZ Leuven, Leuven, Belgium.
¹⁶ Klinik für Radiologie und Nuklearmedizin Universität Basel, Basel, Switzerland.
¹⁷ Department Oncology, Section Hematology and Palliative Care AK Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany.
¹⁸ Faculty of Medicine, Università della Campania L. Vanvitelli Naples, Caserta, Italy.

PMID: 30285213
DOI: 10.1093/annonc/mdy308

Erratum in

Correction to: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".
Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, Nault JC, Neumann U, Ricke J, Sangro B, Schirmacher P, Verslype C, Zech CJ, Arnold D, Martinelli E. Vogel A, et al. Ann Oncol. 2019 May 1;30(5):871-873. doi: 10.1093/annonc/mdy510. Ann Oncol. 2019. PMID: 30715202 No abstract available.
Corrigendum to "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255].
Vogel A, Cervantes A, Chau I, Daniele B, Llovet JM, Meyer T, Nault JC, Neumann U, Ricke J, Sangro B, Schirmacher P, Verslype C, Zech CJ, Arnold D, Martinelli E; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Vogel A, et al. Ann Oncol. 2022 Jun;33(6):666. doi: 10.1016/j.annonc.2022.03.009. Epub 2022 Mar 30. Ann Oncol. 2022. PMID: 35365377 No abstract available.

No abstract available

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Affiliations

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Authors

Affiliations

Erratum in

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical